BRISTOL MYERS SQUIBB S.A.U. secures contract for Antineoplastic agents - Acquisition of the drug Abecma 260-500 x 10e6 cells dispersion for perfusion (Idecabtagen Vicleucel), destined for the Pharmacy Service, of the Ramon y Cajal University Hospital

Spain, Jan. 27 -- Spain based BRISTOL MYERS SQUIBB S.A.U. has secured contract from HOSPITAL UNIVERSITARIO RAMON Y CAJAL for Antineoplastic agents - Acquisition of the drug Abecma 260-500 x 10e6 cells dispersion for perfusion (Idecabtagen Vicleucel), destined for the Pharmacy Service, of the Ramon y Cajal University Hospital. The value of the contract is worth 183168000 EUR.

Published by HT Digital Content Services with permission from Pivotal Sources....